31 results
8-K
EX-3.2
LABP
Landos Biopharma Inc
23 May 24
AbbVie Completes Acquisition of Landos Biopharma
4:29pm
.
The following definitions shall apply:
(1) The term “proceeding” shall be broadly construed and shall include, without limitation, the investigation
DEFM14A
LABP
Landos Biopharma Inc
25 Apr 24
Proxy related to merger
5:07pm
aware after the date thereof.
Jefferies made no independent investigation of, and Jefferies expressed no view or opinion as to, any legal, regulatory … or submission in connection with any investigation or other inquiry, including allowing the other parties to have a reasonable opportunity to review in advance
PREM14A
LABP
Landos Biopharma Inc
15 Apr 24
Preliminary proxy related to merger
5:18pm
or matter affecting Jefferies’ opinion of which Jefferies becomes aware after the date thereof.
Jefferies made no independent investigation of, and Jefferies … respects and consult with the other parties in connection with any filing or submission in connection with any investigation or other inquiry
DEFA14A
LABP
Landos Biopharma Inc
25 Mar 24
Additional proxy soliciting materials
9:19am
review and there is no inquiry or investigation by the SEC, or any internal investigation pending or threatened, in each case, regarding any accounting … or investigation from any Person relating to their Processing of Personal Information or to any alleged non-compliance with applicable Privacy Laws
8-K
EX-2.1
LABP
Landos Biopharma Inc
25 Mar 24
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
8:54am
or investigation by the SEC, or any internal investigation pending or threatened, in each case, regarding any accounting practice of the Company.
Section … and the Company Subsidiaries have not received any written notice, order, warning, complaint, claim, allegation or investigation from any Person
S-3
EX-4.2
smfn8babooy1zdivnzun
24 Mar 22
Shelf registration
5:26pm
S-8
EX-99.3
z0ptx33iv 710
24 Mar 22
Registration of securities for employees
5:21pm
8-K
EX-99.1
zkc04y3 km
22 Sep 21
Regulation FD Disclosure
8:00am
8-K
EX-99.1
vq31f95c1fg
13 Apr 21
Landos Biopharma Announces the Appointment of Tiago Girão to its Board of Directors
9:01am
10-K
9n7ddovkkxo pg72yg
31 Mar 21
Annual report
5:03pm
424B4
uig6dbls5hwml96cbfp
4 Feb 21
Prospectus supplement with pricing info
5:02pm